Desk›Chemicals› Privi Speciality Chemicals Ltd
Privi Speciality Chemicals Ltd
BSE 530117 · NSE PRIVISCL · ISIN INE959A01019 · Group A · Active
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
₹3,457.70
-0.06%
BSE close, 28 August 2026
₹13,506.71 cr
3.9 cr shares · Small cap
₹5,289.63 cr
as published
36.2× · 13.63×
EPS ₹95.49 · BV ₹253.68
2,455.54 / 357.44
₹ cr, as filed
17
4 selected · 24%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -8.4% |
|---|---|
| Against 52-week low | +57.2% |
| Day change | -0.06% |
| Size band | Small cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹95.49 |
|---|---|
| Price / earnings | 36.21× |
| Price / book | 13.63× |
| Book value — derived, price ÷ P/B | ₹253.68 |
| Return on equity | 37.63% |
| Operating margin | 26.67% |
| Net margin | 14.03% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 37.64%
- ROE as published
- 37.63%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 600.59 | 84.26 | 21.57 | 26.67% | 14.03% |
| Mar-26 · Q | 660.35 | 102.72 | 26.30 | 28.06% | 15.56% |
| FY25-26 | 2,455.54 | 357.44 | 91.50 | 27.53% | 14.56% |
Quarter on quarter
- Revenue, quarter on quarter
- -9.0%
- Net profit, quarter on quarter
- -18.0%
- Operating margin, quarter on quarter
- -139 bps
Disclosure profile 17 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 4 |
| Procedural | |
| Analyst / Investor Meet | 4 |
| AGM / EGM | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Court Convened Meeting | 1 |
| General | 1 |
| Newspaper Publication | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 13 |
| Total | 17 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
17 filings · 4 selected · busiest 2026-07-30
Filing rhythm · the twelve most recent
2026-07-312026-10-07
SelectedProcedural
Filings
17 in the window · 10 earlier on record
-
7 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
6 October 2026 ·
Notice Of Meeting Of Equity Shareholders (Meeting) Of The Company Convened In Accordance With The Order Of The Hon'Ble National Company Law Tribunal, Mumbai Bench
Notice of Hon'ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.
Company Update / General View filing →
-
25 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Funds
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 September 2026 ·
Newspaper Publication
Newspaper Publication of Notice Convening Meeting of Equity Shareholders (Meeting) of the Company Convened in accordance with the order of the Hon'ble National Company Law Tribunal, Mumbai Bench.
Company Update / Newspaper Publication View filing →
-
24 September 2026 ·
Shareholders Meeting- NCLT Convened Meeting On October 27,2026.
Notice of Meetinfg of Equity Shareholders (Meeting) of the Company convened in accordance with the order of the Hon'ble National Company Law Tribunal, Mumbai Bench, to be held through ....
AGM/EGM / Court Convened Meeting View filing →
-
24 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window for the second quarter and half year ending September 30,2026.
Insider Trading / SAST / Closure of Trading Window View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Company Update / Analyst / Investor Meet View filing →
-
11 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Institutional Investor Meeting to be held on August 18,2026.
Company Update / Analyst / Investor Meet View filing →
-
10 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report on the voting results of the business transacted at the 41st Annual General Meeting (AGM)
AGM/EGM / AGM View filing →
-
7 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of the Proceedings of 41st (Forty First) Annual General Meeting of the Company held on Friday August 07,2026.
AGM/EGM / AGM View filing →
-
3 August 2026 ·
Earnings Call Transcript
Transcript of Earning Call held on Friday July 31, 2026.
Company Update / Earnings Call Transcript View filing →
-
31 July 2026 ·
Analyst / Investor Meet - Outcome
Audio Recording of Analyst/ Investors Meet held on Friday July 31,2026.
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Investor Presentation
Investors Presentation - Financial and Operation Review for quarter ended June 30,2026.
Company Update / Investor Presentation View filing →
-
30 July 2026 ·
Unaudited Financial Results For The Quarter Ended June 30,2026.
Unaudited Financial Results for the Quarter ended June 30,2026.
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E Thursday, July 30,2026 For Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For Quarter Ended June 30,2026.
Outcome of the Board Meeting held today i.e Thursday July 30,2026 for approval of unaudited standalone and consolidated Financial Results of the Company for quarter ended June 30,2026.
Board Meeting / Outcome of Board Meeting View filing →
-
23 July 2026 ·
Analyst / Investor Meet - Intimation
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet- Intimation of Q1 Earnings call.
Company Update / Analyst / Investor Meet View filing →
-
22 July 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, July 30, 2026.
Privi Speciality Chemicals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Intimation of Board ....
Board Meeting / Board Meeting View filing →
RSS feed for Privi Speciality Chemicals Ltd · the 50 most recent filings